reprocessing, destruction, and record management.

3. Responsibilities

• Warehouse Staff: Receive returned product and initiate documentation.
• QA Officer/Executive: Conduct visual inspection, initiate investigation, and coordinate evaluation.
• QC Department: Perform required testing on returned samples, if necessary.
• Head – QA: Make final disposition decision (e.g., reprocess, destroy, or release).
• Customer Service: Provide reason for return, handling instructions, and customer communication records.

4. Accountability

The Head of QA is accountable for ensuring that all returned drug products are handled in accordance with applicable regulations, product integrity standards, and company policies.

5. Procedure

5.1 Receipt of Returned Drug Product

1. Upon arrival of returned product, Warehouse staff shall:
   • Verify transport documentation
   • Segregate the product from usable stock
   • Label clearly as “Returned Material – Quarantine”
   • Initiate Return Receipt Form (Annexure-1)

5.2 Documentation Requirements

1. QA shall ensure the following information is collected:
   • Product name, batch number, quantity returned
   • Reason for return (damage, expiry, quality issue, temperature deviation)
   • Customer complaint or communication details
   • Transport and storage conditions during return

5.3 Visual and Preliminary Inspection

1. QA shall perform visual inspection of returned containers for:
   • Seal integrity
   • Label condition
   • Physical damage
   • Cross-contamination risk
2. Record observations in Return Evaluation Form (Annexure-2).

5.4 Evaluation and Risk Assessment

1. QA, in coordination with QC and Production, shall evaluate:
   • Stability concerns due to environmental exposure
   • Possibility of contamination or mix-up
   • Retention samples comparison (if available)
   • Need for reanalysis or reprocessing
2. QC may test returned samples for assay, impurities, moisture, and microbial count if required.

5.5 Disposition Decision

1. Based on findings, QA Head shall decide whether:
   • The product is suitable for reprocessing
   • The product may be returned to stock (in rare cases)
   • The product must be destroyed
2. Record the final disposition decision in Disposition Form (Annexure-3).

5.6 Handling of Approved Returns

1. If returned product is suitable for reprocessing:
   • Initiate batch reprocessing protocol
   • Revise BMR accordingly
   • Retest and release via QA as per reprocessing SOP
2. All steps must be approved before execution.

5.7 Handling of Rejected Returns

1. If product is rejected:
   • Label as “To Be Destroyed”
   • Transfer to rejection area
   • Destroy as per site destruction SOP with QA witness
2. Destruction details must be entered in the Destruction Log (Annexure-4).

5.8 Record Keeping and Trending

1. All returned product records must be maintained for at least 5 years.
2. QA shall compile quarterly return summary reports (Annexure-5) including:
   • Number of returns
   • Return reasons
   • Disposition trends
3. Discussed during management review and APQR.

6. Abbreviations

• QA: Quality Assurance
• QC: Quality Control
• BMR: Batch Manufacturing Record
• APQR: Annual Product Quality Review

7. Documents

1. Return Receipt Form (Annexure-1)
2. Return Evaluation Form (Annexure-2)
3. Disposition Form (Annexure-3)
4. Destruction Log (Annexure-4)
5. Quarterly Return Summary Report (Annexure-5)

8. References

• 21 CFR 211.204 – Returned Drug Products
• ICH Q10 – Pharmaceutical Quality System
• EU GMP Part I – Chapter 8 (Complaints and Product Recall)

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Return Receipt Form

Date	Product	Batch No.	Qty Returned	Customer	Reason
12/04/2025	API-X	AXB2025	25 kg	Client A	Seal damage

Annexure-2: Return Evaluation Form

Parameter	Observation	Remarks
Seal Condition	Intact	Acceptable
Labeling	Clear	Legible
Container Damage	None	OK

Annexure-3: Disposition Form

Batch No.	Disposition	QA Decision	Date
AXB2025	Reprocess	Approved	13/04/2025

Annexure-4: Destruction Log

Date	Batch No.	Qty Destroyed	Method	Witness
14/04/2025	AXC2025	10 kg	Incineration	QA Officer

Annexure-5: Quarterly Return Summary Report

Quarter	Total Returns	Major Reasons	% Reprocessed	% Destroyed
Q1 2025	4	Seal leakage, Label smudge	50%	50%

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
01/01/2022	1.0	Initial SOP	New document	QA Head
14/04/2025	2.0	Added return summary reporting and destruction log	Process improvement	QA Head